Marrone Bio Innovations (MBII) 10-Q2019 Q3 Quarterly report

Filed: 19 Nov 19, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. senior Avg

New words: AB, accrual, admission, Aid, al, amaranth, Analogizing, anniversary, assist, assume, assumed, Austin, awarded, Bab, behavior, bionutrition, biotechnology, Black, blight, Brasil, capable, Carlo, Centre, chayote, Comercio, commitment, confidentiality, Council, cucumber, cultivated, de, demonstrated, downy, drew, enforcing, environment, equivalent, Euribor, factor, factoring, familiar, foliar, Foramin, forma, garden, Glinatur, guarantee, guaranteed, guarantor, hemisphere, highlighted, imputed, insignificant, Instability, intangible, iv, Kelta, Khail, lapse, largest, Lawsuit, local, ltda, LumiBio, macroeconomic, melon, methodology, Mexico, midpoint, Ministry, Monte, multibillion, multiperiod, national, nonrecurring, Nordea, OU, palmer, penetration, plain, political, post, potato, pre, prejudice, preliminary, profile, repaid, Russia, SA, SAB, screen, simplified, southern, squash, study, tightly, translated, translation, Treasury, treated, univariate, unrelated, vanilla, watermelon, weed, withASC, yearly, yield, zucchini

Removed: begin, derivate, determinable, largely, merit, presently, repurposed, settled, shown, weissued

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated MBII transcripts

MBII similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Pamela G. Marrone, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Marrone Bio Innovations, Inc. on Form 10-Q for the fiscal quarter ended September 30, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Marrone Bio Innovations, Inc.

Date: November 18, 2019

	By:	/s/ Pamela G. Marrone
	Name:	Pamela G. Marrone
	Title:	Chief Executive Officer

I, James B. Boyd, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Marrone Bio Innovations, Inc. on Form 10-Q for the fiscal quarter ended September 30, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Marrone Bio Innovations, Inc.

Date: November 18, 2019

	By:	/s/ James B. Boyd
	Name:	James B. Boyd
	Title:	President and Chief Financial Officer

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.